TrialJournal of neuro-oncology2025

Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab.

Shivani Ahlawat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.